JP3634200004 (JP3634200004)

$497.2B
Market Cap
11.8
P/E Ratio
0.32
Beta
2.60%
Dividend Yield
Piotroski 8/9Altman Z 3.3 SafeROIC−WACC +0.0%

Quantitative Summary

Deterministic

Financial health metrics are strong: Piotroski 8/9, Altman Z 3.3 (above 3.0 safe zone threshold).

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation profile presents a nuanced picture of operational efficiency versus growth momentum. While the DuPont decomposition reveals that profitability is driven primarily by margins rather than asset turnover or leverage, with net and gross margins at 3.4% and 15.1% respectively, the return on invested capital generates only a narrow spread over the cost of equity. This results in an ROIC-WACC differential of just +0.9%, suggesting limited value creation from new investments despite strong financial stability indicators. The balance sheet remains robust with an Altman Z-Score of 3.3, indicating low bankruptcy risk, and operational resilience is further underscored by a Piotroski F-Score of 8/9, reflecting superior fundamental quality relative to peers even as revenue contraction persists at -1.1% year-over-year.

Valuation metrics currently reflect significant market skepticism regarding future growth trajectories despite the company's solid credit profile. Trading at a forward P/E multiple of 11.8x, which appears compressed relative to historical norms and sector averages given the high Piotroski score, implies that investors are heavily discounting earnings power rather than penalizing balance sheet weakness. A discounted cash flow analysis suggests an intrinsic fair value of $5229 per share; however, without explicit current market price data or implied growth rate assumptions provided in the input, determining whether this valuation represents a premium or discount requires external context not available within the supplied dataset. The divergence between high-quality fundamentals and negative revenue trends indicates that pricing is likely driven by concerns over top-line sustainability rather than solvency issues.

Risk assessment highlights a potential opportunity cost associated with low capital efficiency. Although the Altman Z-Score confirms minimal distress risk, the marginal ROIC-WACC spread of 0.9% suggests that shareholder value creation may lag behind alternative investments offering higher returns on similar-risk profiles. The combination of declining revenue and thin net margins creates an environment where even slight margin compression could erode the already modest economic moat. Consequently, while downside protection appears anchored by a strong balance sheet and high F-Score, upside potential remains constrained unless operational leverage improves or top-line dynamics reverse to support higher valuation multiples consistent with its fundamental quality scores.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →6%7.4%9.4%
2%$17767$13038$9328
3%$23076$15609$10523
4%$33693$19703$12162

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=7.4%, terminal growth 3%. Fair value $15609 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

8/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
3.3
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.

Profitability & Value Creation

15.1%
Gross Margin
3.4%
Net Margin
7.4%
ROIC
7.4%
WACC
ROIC − WACC Spread: +0.0%— Positive spread.
-1.1%
Revenue Growth (YoY)
-29.4%
Earnings Growth (YoY)
33.6B
Free Cash Flow
40%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

Balance Sheet Health

0.55x
Debt / Equity
2.36x
Current Ratio
7.7x
Interest Coverage
-0.2x
Net Debt / EBITDA
7.17%
FCF Yield
121.3B
EBITDA

Earnings Surprise History

Q3
✓ Beat
Est: $25.88
Act: $31.99
+23.6%
Q2
✓ Beat
Est: $105.51
Act: $112.18
+6.3%
Q1
✓ Beat
Est: $106.43
Act: $127.16
+19.5%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

12.1
Forward P/E
PEG Ratio
0.91
Price/Book
1M
Avg Volume
$5230.00
52W High
$2201.00
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$18M
Tracked Passive Exposure
3
ETFs Holding JP3634200004
0.01%
Avg Weight in ETFs
$278B
Total ETF AUM

When investors buy or sell ETFs like SCHF or IEFA, the fund manager is mechanically forced to buy or sell JP3634200004 shares regardless of JP3634200004's individual fundamentals. We estimate $18M of passive capital is structurally linked to JP3634200004 through 3 tracked ETFs. Passive flows have a limited but growing influence on JP3634200004's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 3 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in JP3634200004 to visualize passive redemption contagion across ETFs and collateral stocks.

JP3634200004 Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
JP3634200004EpicenterIEFAETFSCHFETFIXUSETFNL0010273215Low RiskTW0002330008Low RiskCH0012032048Low RiskCH0012005267Low RiskKR7005930003Low Risk
JP3634200004 Price Drop (%)0

If JP3634200004 (JP3634200004) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies ASML Holding N.V. (NL0010273215) as the most exposed collateral stock, sharing 2 ETFs with JP3634200004. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 3 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

JP3634200004 Ownership Dynamics

Ticker
JP3634200004

Float lock-up computed from 3 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

JP3634200004 Capital Efficiency

How efficiently does JP3634200004 convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$33.6B
EBITDA
$121.3B
FCF Conversion
28%
Reinvestment Rate
72%
28% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
7.4%
ROIC − WACC Spread
0.0%

JP3634200004 converts 28% of its EBITDA into free cash flow, a moderate conversion rate — significant EBITDA is consumed by capital expenditures, working capital changes, or interest payments. The 72% reinvestment rate signals aggressive capacity expansion. The positive ROIC-WACC spread of 0.0% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Compare JP3634200004 to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.